Despite 95%+ full vaccination of adult populations in Australia, TrialSite has continued to report on surges in new COVID-19 cases, hospitalizations, and deaths. It is a disturbing situation that the mainstream press either completely ignores or summarily embraces as a context to promote further vaccination as the only answer. But is this an evidence-based approach to the problem? TrialSite reported that in the first 14 weeks of 2022, Australian fatalities due to COVID-19 were double that of 2020 and 2021 combined, despite near universal vaccination. By January 2022, TrialSite updated the global audience that in Australian states including New South Wales or “NSW,” the new increasingly Omicron-based cases were surging. TrialSite reviewed the latest data. Now, with a surge in B.4 and B.5 Omicron subvariants which more evade vaccine induced antibodies, a disturbing number of deaths are reported daily. What’s the level of protection the vaccines are affording to the population of NSW now that these subvariants circulate through this southeastern part of Australia?
With 8.1 million people, NSW is Australia’s most populated state which includes the nation’s biggest city of Sydney. NSW Health oversees the collection, organization, and presentation of COVID-19 data for the Australian state.
Over the last 24 hours the state health agency reports on an increase in new COVID-19 cases, as transmissible Omicron-based mutated pathogens circulate the region, infecting human hosts. New cases absolutely exploded in 2022, shattering all records during the pandemic. This was due in part to Australia’s zero-tolerance COVID policy approach similar to Mainland China, which locked down much of society while “protecting” the population from the pathogen. TrialSite has written extensively on this topic.
Vaccination Status
NSW Health reports the following vaccination data in the southeastern Australian state:
Cohort
% Vaccinated
Age 16 and above fully vaccinated (2 dose)
95.1%
Age 16 and above boosted (3+ dose)
64.4%
Age 12 to 15 with 2 doses
78.9%
Age 5 to 11 with one dose or more
49.7%
What’s the data telling us?
While NSW Health points out the unvaccinated are far more impacted by serious SARS-CoV-2 than the vaccinated, the majority of the population are, in fact, vaccinated. Most individuals hospitalized or deceased due to COVID-19 are also vaccinated.
The vaccine is not doing enough to protect Australian people from hospitalization and mortality due to the circulating variant pathogens. What follows is hospitalization, ICU, and death data associated with COVID-19 for week 24 ending June 18th.
Vaccination Status
Hospitalized (no ICU)
Admitted to ICU
Death
4 doses
72
5
8
3 doses
189
24
48
2 doses
105
5
15
1 dose
8
0
2
No dose
4
1
4
Unknown
128
12
0
Total
506
47
77
Generally, health care agencies around the world report that the current COVID-19 vaccines have reduced the risk of hospitalization and death, and this proportionally may still be a reality. However now that in NSW a majority of state residents are fully vaccinated, the hospitalization and deaths should be contained or on a downward trend. Moreover, it would be expected that given the majority of residents of NSW have received two doses, that that group would associate with more deaths.
TrialSite suggests a confluence of factors interact to heighten risk of hospitalization and death including 1) COVID-19 vaccine durability challenges (waning effectiveness against mutating pathogens); 2) mutating variants and subvariants that vaccine manufacturers face challenges keeping up with; 3) the overall surge in new cases due to a combination of highly transmissible variants/sub-variants and less natural immunity generally present; 4) Australia’s rigid zero-tolerance COVID policy during the pandemic. All these combined equal heightened risk for the elderly and immunocompromised.
It turns out that the elderly in Australia generally are getting three and four doses significantly more than younger cohorts. They, of course, do this as it is recommended for elderly and immunocompromised. Acknowledging risks for hospitalization and death for even those NSW residents boosted with a third or even fourth dose, NSW Health cautions:
“Despite the substantial protection from COVID-19 provided by vaccination, older age remains a significant risk factor for serious illness and death with COVID-19, particularly when combined with significant underlying health conditions.”
The data for the week ending June 18th reveals that 94.8% of NSW residents that passed away due to COVID-19 were vaccinated. This is comparable to the total percent of vaccinated adults. Unvaccinated adults represent just under 5% of the population, and for week 24 in NSW they represent 5% of the COVID-19 deaths. This statistic can be misleading because SARS-CoV-2 is far riskier of a disease for the elderly and immunocompromised.
We observe here that 62% of the deaths due to COVID-19 are among individuals that received three jabs. Again, this doesn’t mean that the vaccines don’t work at all. That would be a misleading statement. But the data has repeatedly suggested that despite three doses, the elderly continue to face higher risks for hospitalization and/or death, and NSH Health acknowledges this in their statement quoted above warning of the risk for serious illness and death regardless of vaccination or not.
Excluded from this conversation are the health risks associated with the COVID-19 vaccines. While the mRNA vaccines developed by Pfizer-BioNTech and Moderna are deemed safe and effective from health authority’s actual emergency authorization or formal approval, cautionary points are raised, including the risk of myocarditis in young males.
But a range of vaccine injuries are being reported around the world yet not analyzed systematically by governments. Generally, health authorities and regulators have opted to weigh the risk of infection far higher than any short-term or at presently unknown long-term risks associated with the developed countermeasures (vaccines).
According to the most recent statistics 40 persons have died in NSW due to COVID-19 in the past 24 hours. See the reference in local media reporting on the growing presence of BA.4 and BA.5.
References
Despite 95%+ full vaccination of adult populations in Australia, TrialSite has continued to report on surges in new COVID-19 cases, hospitalizations, and deaths. It is a disturbing situation that the mainstream press either completely ignores or summarily embraces as a context to promote further vaccination as the only answer. But is this an evidence-based approach to the problem? TrialSite reported that in the first 14 weeks of 2022, Australian fatalities due to COVID-19 were double that of 2020 and 2021 combined, despite near universal vaccination. By January 2022, TrialSite updated the global audience that in Australian states including New South Wales or “NSW,” the new increasingly Omicron-based cases were surging. TrialSite reviewed the latest data. Now, with a surge in B.4 and B.5 Omicron subvariants which more evade vaccine induced antibodies, a disturbing number of deaths are reported daily. What’s the level of protection the vaccines are affording to the population of NSW now that these subvariants circulate through this southeastern part of Australia?
With 8.1 million people, NSW is Australia’s most populated state which includes the nation’s biggest city of Sydney. NSW Health oversees the collection, organization, and presentation of COVID-19 data for the Australian state.
https://www.trialsitenews.com/a/majority-of-covid-19-deaths-among-australia-nsw-residents-triple-quadruple-vaxxed-66b6eefc